MedPath

The effect of Autologous Serum Therapy in Chronic Spontaneous Urticaria

Not Applicable
Conditions
Chronic spontaneous urticaria.
Other urticaria
Registration Number
IRCT20180113038328N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Symptoms lasting more than 6 weeks
Negative Prick test for oral and inhalatory allergens
Aged higher than 15 years
Normal laboratory result for CBC/diff - S/E - U/A-LFT-HBsAg-BUN-Cr-ESR-CRP-CH50-ANA-IgE and anti-Helicobacter pylori tests

Exclusion Criteria

Physical urticaria
Allergic and drug urticaria
Vasculitis urticaria
Cortisone and immunosuppressive use over the past 6 weeks (other than antihistamines)
Pregnancy
Lactation
Other systemic diseases.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spontaneous chronic urticaria is a qualitative variable with clinical parameters and cytokines is a of quantity Variable that is measured with PCR. Timepoint: Before and after treatment, as well as 4 weeks after the completion of treatment. Method of measurement: Urticaria total severity score (TSS) ,dermatology quality of life index (DLQI),Real-time-PCR.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath